$2.8M Zolgensma spinal muscular atrophy treatment approved by Health Canada
Health Canada has approved Zolgensma, a $2.8 million life-saving gene therapy for toddlers that replaces the dysfunctional gene which causes spinal muscular atrophy Type 1. As Morgan Black explains on the noon news, it's exciting news for several Alberta families.
UP NEXT
NOW PLAYING: other
$2.8M Zolgensma spinal muscular atrophy treatment approved by Health Canada
UP NEXT
-
More patients now asking about getting 2nd doses of COVID-19 vaccines in Alberta
-
AstraZeneca COVID-19 vaccine uptake increasing as supply dwindles in Alberta
-
Albertans urged to get a COVID-19 vaccine as more become eligible
-
Kenney responds to negative value Canadian oil
-
How oil prices have recovered, 1 year after WTI dropping below zero
-
Trans Mountain pipeline project clears another hurdle
-
Canada’s doctors call for national vaccination strategy
-
Where is the ‘superspreader’ event? Few details available on birthday party outbreak described by Alberta premier
-
How are Edmonton school boards faring as others in Alberta move back to at-home learning?
-
Dr. Deena Hinshaw pens letter to Alberta’s hard-hit entertainment venues
-
Alberta premier commits to give direction on Calgary Stampede soon
-
Alberta’s new measures aim to curb COVID-19 surge among youth
-
Alberta on track to administer 300,000 COVID-19 vaccines per week, premier says | FULL
-
Alberta doctors say renewed restrictions not enough to curb COVID-19 spread
-
Albertans continue to push back against draft curriculum
-
NDP says new Alberta curriculum will be tossed if elected in 2023
![image beacon](https://web.vortex.data.msn.com/collect/v1/t.gif?name=%27Ms.Webi.PageView%27&ver=%272.1%27&appId=%27JS%3AMSN%27&ext-app-env=%27prod%27&ext-javascript-libver=%274.0.0-beta-10%27&ext-user-localId=%27t%3A10C27DB1E29667B80F546D93E384662A%27&*baseType=%27Ms.Content.PageView%27&*isJs=False&*title=%27%27&*isLoggedIn=False&*isManual=True&*serverImpressionGuid=%276b7f102e-e60a-43ca-b0b3-edf5cd5ce76d%27&-ver=%271.0%27&-impressionGuid=%276b7f102e-e60a-43ca-b0b3-edf5cd5ce76d%27&-pageName=%27channelplayerpage%27&-uri=%27https%253A%252F%252Fwww.msn.com%252Fen-ca%252Fnews%252Fother%252Fdollar28m-zolgensma-spinal-muscular-atrophy-treatment-approved-by-health-canada%252Fvp-BB1dVoJW%27&-referrerUri=%27%27&-pageTags=%27{"pg.t"%3A"video"%2C"pg.p"%3A"prime"%2C"pg.c"%3A""%2C"ex"%3A""%2C"rid"%3A"6b7f102ee60a43cab0b3edf5cd5ce76d"%2C"clid"%3A"10C27DB1E29667B80F546D93E384662A"%2C"clidType"%3A"muid"%2C"di"%3A"13987"%2C"partner"%3A"Global%2BNews"%2C"publcat"%3A"Corus%2BTelevision%2BLimited%2BPartnership"%2C"cvs"%3A"Browser"%2C"subcvs"%3A"news"%2C"entityId"%3A"BB1dVoJW"%2C"entitySrc"%3A"vp"%2C"provid"%3A"BBoSGQ8"%2C"dpt"%3A"other"%2C"sdpt"%3A""%2C"ar"%3A"0"%2C"dgk"%3A"downlevel.pc"%2C"imd"%3A"0"%2C"parentId"%3A""%2C"pgIdx"%3A""%2C"pgTot"%3A""%2C"anoncknm"%3A""%2C"afd"%3A""%2C"issso"%3A"0"%2C"aadState"%3A"0"}%27&-behavior=0&-market=%27en-ca%27){kind=small}